Journal article
Phase I/II study of the deacetylase inhibitor panobinostat after allogeneic stem cell transplantation in patients with high-risk MDS or AML (PANOBEST trial)
Authors
Bug G; Burchert A; Wagner E-M; Kröger N; Berg T; Güller S; Metzelder SK; Wolf A; Hünecke S; Bader P
Journal
Leukemia, Vol. 31, No. 11, pp. 2523–2525
Publisher
Springer Nature
Publication Date
November 1, 2017
DOI
10.1038/leu.2017.242
ISSN
0887-6924